Treatments used for obsessive–compulsive disorder—An international perspective

Abstract

Objective The objective of this study was to characterise international trends in the use of psychotropic medication, psychological therapies, and novel therapies used to treat obsessive–compulsive disorder (OCD). Methods Researchers in the field of OCD were invited to contribute summary statistics on the characteristics of their samples. Consistency of summary statistics across countries was evaluated. Results The study surveyed 19 expert centres from 15 countries (Argentina, Australia, Brazil, China, Germany, Greece, India, Italy, Japan, Mexico, Portugal, South Africa, Spain, the United Kingdom, and the United States) providing a total sample of 7,340 participants. Fluoxetine (n = 972; 13.2%) and fluvoxamine (n = 913; 12.4%) were the most commonly used selective serotonin reuptake inhibitor medications. Risperidone (n = 428; 7.3%) and aripiprazole (n = 415; 7.1%) were the most commonly used antipsychotic agents. Neurostimulation techniques such as transcranial magnetic stimulation, deep brain stimulation, gamma knife surgery, and psychosurgery were used in less than 1% of the sample. There was significant variation in the use and accessibility of exposure and response prevention for OCD. Conclusions The variation between countries in treatments used for OCD needs further evaluation. Exposure and response prevention is not used as frequently as guidelines suggest and appears difficult to access in most countries. Updated treatment guidelines are recommended.

Is it time to change the gold standard of obsessive-compulsive disorder severity assessment? Factor structure of the Yale-Brown Obsessive-Compulsive Scale

“…However, this hypothesis is unlikely, considering that studies from diverse countries have found similar results (fair to mediocre model fit, as well as low factor loadings for these items). More importantly, the Brazilian Portuguese version has been used in several studies since the 1990s, showing consistent results, even in the context of multinational studies (Brakoulias et al, 2017, 2019; Boedhoe et al, 2017, 2018; Fouche et al, 2017; Kong et al, 2019). Furthermore, our findings derive from a multicenter study with dozens of evaluators that assessed patients with OCD in different Brazilian regions.…”

Schizophrenia: Epidemiology, Causes, Neurobiology, Pathophysiology, and Treatment

“…More precise forms of psychosurgery are still performed in very few cases but are mostly used to treat obsessivecompulsive disorder (Brakoulias et al, 2019). Nevertheless, the idea of using psychosurgery to treat schizophrenia has recently re-emerged, albeit in a far more subtle and less invasive forms.…”

Effectiveness, Timing and Procedural Aspects of Cognitive Behavioral Therapy after Deep Brain Stimulation for Therapy-Resistant Obsessive Compulsive Disorder: A Systematic Review

“…In addition, CBT provides the patient with new coping styles and problem solving skills that may be important to prevent relapse and contribute to the long-term efficacy of DBS. Whereas guidelines for CBT in OCD have suggested offering CBT after DBS, clinical practice varies widely across institutions and often depends on local possibilities and traditions [ 9 , 10 ]. A more uniform and evidence-based approach may be beneficial for patients.…”